Estimating neurotransmitter kinetics with ntPET: A simulation study of temporal precision and effects of biased data

NeuroImage

Volumn 39, Issue 3, 2008, Pages 1162-1179

  Normandin, Marc D ^a,b   Morris, Evan D ^a,b,c  

^a PURDUE UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Indiana University Purdue University Indianapolis   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ARTICLE; BRAIN BLOOD FLOW; COMPARTMENT MODEL; COMPUTER SIMULATION; KINETICS; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR DENSITY;

ALGORITHMS; BIAS (EPIDEMIOLOGY); BRAIN CHEMISTRY; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CEREBRAL ARTERIES; CEREBROVASCULAR CIRCULATION; COMPUTER SIMULATION; ETHANOL; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; KINETICS; MICRODIALYSIS; MODELS, STATISTICAL; NEUROTRANSMITTER AGENTS; POSITRON-EMISSION TOMOGRAPHY; REPRODUCIBILITY OF RESULTS;

EID: 37849052700     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2007.09.046     Document Type: Article

References (72)

1. Alpert N.M., Badgaiyan R.D., Livni E., and Fischman A.J. A novel method for noninvasive detection of neuromodulatory changes in specific neurotransmitter systems. NeuroImage 19 (2003) 1049-1060
2. 11C]FLB 457: re-evaluation of the validity of using a cerebellar reference region. J. Cereb. Blood Flow Metab. 27 (2007) 378-392
3. Aston J.A., Gunn R.N., Worsley K.J., Ma Y., Evans A.C., and Dagher A. A statistical method for the analysis of positron emission tomography neuroreceptor ligand data. NeuroImage 12 (2000) 245-256
4. Bertoldo A., Sparacino G., and Cobelli C. "Population" approach improves parameter estimation of kinetic models from dynamic PET data. IEEE Med. Trans. Imag. 23 (2004) 297-306
5. Blomqvist G., Pauli S., Farde L., Eriksson L., Persson A., and Halldin C. Maps of receptor binding parameters in the human brain-A kinetic analysis of PET measurements. Eur. J. Nucl. Med. 16 (1990) 257-265
6. 11C]raclopride study with amphetamine. J. Neurosci. 27 (2007) 3998-4003
7. 3 dopamine receptor binding with [F-18]fallypride in thalamus and cortex of patients with schizophrenia. Schizophr. Res. 85 (2006) 232-244
8. Bungay P.M., Newton-Vinson P., Isele W., Garris P.A., and Justice J.B. Microdialysis of dopamine interpreted with quantitative model incorporating probe implantation trauma. J. Neurochem. 86 (2003) 932-946
9. 18F]-fallypride in monkeys using a PET multiple-injection protocol. J. Cereb. Blood Flow Metab. 24 (2004) 309-322
10. Cumming P., Yokoi F., Chen A., Deep P., Dagher A., Reutens D., Kapczinski F., Wong D.F., and Gjedde A. Pharmacokinetics of radiotracers in human plasma during positron emission tomography. Synapse 34 (1999) 124-134
11. Cunningham V.J., Hume S.P., Price G.R., Ahier R.G., Cremer J.E., and Jones A.K. Compartmental analysis of diprenorphine binding to opiate receptors in the rat in vivo and its comparison with equilibrium data in vitro. J. Cereb. Blood Flow Metab. 11 (1991) 1-9
12. Delforge J., Syrota A., and Mazoyer B.M. Experimental design optimisation: theory and application to estimation of receptor model parameters using dynamic positron emission tomography. Phys. Med. Biol. 34 (1989) 419-435
13. Delforge J., Syrota A., and Mazoyer B.M. Identifiability analysis and parameter identification of an in vivo ligand-receptor model from PET data. IEEE Trans. Biomed. Eng. 37 (1990) 653-661
14. 2 receptors using a very high-affinity ligand (FLB 457) and the multi-injection approach. J. Cereb. Blood Flow Metab. 19 (1999) 533-546
15. Dewey S.L., Smith G.S., Logan J., Brodie J.D., Simkowitz P., MacGregor R.R., Fowler J.S., Volkow N.D., and Wolf A.P. Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography in normal human subjects. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 11816-11820
16. 11C]raclopride: combined PET-microdialysis studies. J. Cereb. Blood Flow Metab. 17 (1997) 932-942
17. A receptor mutation causing generalized epilepsy reduces benzodiazepine receptor binding. NeuroImage 32 (2006) 995-1000
18. Feng D., Huang S.C., and Wang X. Models for computer simulation studies of input functions for tracer kinetic modeling with positron emission tomography. Int. J. Biomed. Comput. 32 (1993) 95-110
19. Fisher R.E., Morris E.D., Alpert N.M., and Fischman A.J. In vivo imaging of neuromodulatory synaptic transmission using PET: a review of relevant neurophysiology. Hum. Brain Mapp. 3 (1995) 24-34
20. Friston K.J., Malizia A.L., Wilson S., Cunningham V.J., Jones T., and Nutt D.J. Analysis of dynamic radioligand displacement or "activation" studies. J. Cereb. Blood Flow Metab. 17 (1997) 80-93
21. Frumberg D.B., Fernando M.S., Lee D.E., Biegon A., and Schiffer W.K. Metabolic and behavioral deficits following a routine surgical procedure in rats. Brain Res. 1144 (2007) 209-218
22. Gillings N.M., Bender D., Falborg L., Marthi K., Munk O.L., and Cumming P. Kinetics of the metabolism of four PET radioligands in living minipigs. Nucl. Med. Biol. 28 (2001) 97-104
23. Heinz A., Ragan P., Jones D.W., Hommer D., Williams W., Knable M.B., Gorey J.G., Doty L., Geyer C., Lee K.S., Coppola R., Weinberger D.R., and Linnoila M. Reduced central serotonin transporters in alcoholism. Am. J. Psychiatry 155 (1998) 1544-1549
24. 18F]fluoroethyl)spiperone and dynamic positron emission tomography. J. Cereb. Blood Flow Metab. 9 (1989) 850-858
25. 2 receptor in nonhuman primates. Synapse 10 (1992) 177-184
26. Innis R.B., Cunningham V.J., Delforge J., Fujita M., Gjedde A., Gunn R.N., Holden J., Houle S., Huang S.C., Ichise M., Iida H., Ito H., Kimura Y., Koeppe R.A., Knudsen G.M., Knuuti J., Lammertsma A.A., Laruelle M., Logan J., Maguire R.P., Mintun M.A., Morris E.D., Parsey R., Price J.C., Slifstein M., Sossi V., Suhara T., Votaw J.R., Wong D.F., and Carson R.E. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J. Cereb. Blood Flow Metab. 27 (2007) 1533-1539
27. 11C]flumazenil in human plasma: assessment as the standardized value for quantitative PET studies. Ann. Nucl. Med. 12 (1998) 55-59
28. Koepp M.J., Gunn R.N., Lawrence A.D., Cunningham V.J., Dagher A., Jones T., Brooks D.J., Bench C.J., and Grasby P.M. Evidence for striatal dopamine release during a video game. Nature 393 (1998) 266-268
29. 2(17)O. Magn. Reson. Med. 22 (1991) 154-158
30. Landaw E.M., and DiStefano III J.J. Multiexponential, multicompartmental, and noncompartmental modeling: II. Data analysis and statistical considerations. Am. J. Physiol. 246 (1984) R665-R677
31. Laruelle M., Abi-Dargham A., van Dyck C.H., Rosenblatt W., Zea-Ponce Y., Zoghbi S.S., Baldwin R.M., Charney D.S., Hoffer P.B., Kung H.F., et al. SPECT imaging of striatal dopamine release after amphetamine challenge. J. Nucl. Med. 36 (1995) 1182-1190
32. Litton J.E., Hall H., and Pauli S. Saturation analysis in PET-analysis of errors due to imperfect reference regions. J. Cereb. Blood Flow Metab. 14 (1994) 358-361
33. 11C-methyl]-(-)-cocaine PET studies in human subjects. J. Cereb. Blood Flow Metab. 10 (1990) 740-747
34. 11C]raclopride binding in the brain: model simulations and kinetic analysis of PET data. J. Cereb. Blood Flow Metab. 14 (1994) 995-1010
35. Logan J., Fowler J.S., Volkow N.D., Wang G.J., Ding Y.S., and Alexoff D.L. Distribution volume ratios without blood sampling from graphical analysis of PET data. J. Cereb. Blood Flow Metab. 16 (1996) 834-840
36. Logan J., Ding Y.S., Lin K.S., Pareto D., Fowler J., and Biegon A. Modeling and analysis of PET studies with norepinephrine transporter ligands: the search for a reference region. Nucl. Med. Biol. 32 (2005) 531-542
37. Mach R.H., Nader M.A., Ehrenkaufer R.L., Line S.W., Smith C.R., Gage H.D., and Morton T.E. Use of positron emission tomography to study the dynamics of psychostimulant-induced dopamine release. Pharmacol. Biochem. Behav. 57 (1997) 477-486
38. Millet P., Ibanez V., Delforge J., Pappata S., and Guimon J. Wavelet analysis of dynamic PET data: application to the parametric imaging of benzodiazepine receptor concentration. Neuroimage 11 (2000) 458-472
39. Mintun M.A., Raichle M.E., Kilbourn M.R., Wooten G.F., and Welch M.J. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann Neurol 15 (1984) 217-227
40. Morris E.D., and Yoder K.K. Positron emission tomography displacement sensitivity: predicting binding potential change for positron emission tomography tracers based on their kinetic characteristics. J. Cereb. Blood Flow Metab. 27 (2007) 606-617
41. Morris E.D., Fisher R.E., Alpert N.M., Rauch S.L., and Fischman A.J. In vivo imaging of neuromodulation using positron emission tomography: optimal ligand characteristics and task length for detection of activation. Human Brain Mapping 3 (1995) 35-55
42. Morris E.D., Alpert N.M., and Fischman A.J. Comparison of two compartmental models for describing receptor ligand kinetics and receptor availability in multiple injection PET studies. J. Cereb. Blood Flow Metab. 16 (1996) 841-853
43. 11C-CFT. Synapse 24 (1996) 262-272
44. max?. Synapse 32 (1999) 136-140
45. Morris E.D., Yoder K.K., Wang C., Normandin M.D., Zheng Q.H., Mock B., Muzic Jr. R.F., and Froehlich J.C. ntPET: a new application of PET imaging for characterizing the kinetics of endogenous neurotransmitter release. Mol. Imaging 4 (2005) 473-489
46. Muzic Jr. R.F., and Christian B.T. Evaluation of objective functions for estimation of kinetic parameters. Med Phys 33 (2006) 342-353
47. Muzic Jr. R.F., and Cornelius S. COMKAT: compartment model kinetic analysis tool. J. Nucl. Med. 42 (2001) 636-645
48. Muzic Jr. R.F., Nelson A.D., Saidel G.M., and Miraldi F. Optimal experiment design for PET quantification of receptor concentration. Medical Imaging, IEEE Transactions on 15 (1996) 2-12
49. Normandin M.D., and Morris E.D. Temporal resolution of ntPET using either arterial or reference region-derived plasma input functions. Engineering in Medicine and Biology Society, 2006. EMBS '06. 28th Annual International Conference of the IEEE (2006) 2005-2008
50. O'Sullivan F., and Saha A. Use of ridge regression for improved estimation of kinetic constants from PET data. IEEE Trans Med Imaging 18 (1999) 115-125
51. Ogawa S., Lee T.M., Kay A.R., and Tank D.W. Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 9868-9872
52. Pappata S., Dehaene S., Poline J.B., Gregoire M.C., Jobert A., Delforge J., Frouin V., Bottlaender M., Dolle F., Di Giamberardino L., and Syrota A. In vivo detection of striatal dopamine release during reward: a PET study with [(11)C]raclopride and a single dynamic scan approach. Neuroimage 16 (2002) 1015-1027
53. Picard F., Bruel D., Servent D., Saba W., Fruchart-Gaillard C., Schollhorn-Peyronneau M.A., Roumenov D., Brodtkorb E., Zuberi S., Gambardella A., Steinborn B., Hufnagel A., Valette H., and Bottlaender M. Alteration of the in vivo nicotinic receptor density in ADNFLE patients: a PET study. Brain 129 (2006) 2047-2060
54. Pinborg L.H., Videbaek C., Ziebell M., Mackeprang T., Friberg L., Rasmussen H., Knudsen G.M., and Glenthoj B.Y. [(123)I]Epidepride binding to cerebellar dopamine D(2)/D(3) receptors is displaceable: implications for the use of cerebellum as a reference region. Neuroimage 34 (2007) 1450-1453
55. Schiffer W.K., Mirrione M.M., Biegon A., Alexoff D.L., Patel V., and Dewey S.L. Serial microPET measures of the metabolic reaction to a microdialysis probe implant. J. Neurosci. Methods 155 (2006) 272-284
56. Schiffer W.K., Volkow N.D., Fowler J.S., Alexoff D.L., Logan J., and Dewey S.L. Therapeutic doses of amphetamine or methylphenidate differentially increase synaptic and extracellular dopamine. Synapse 59 (2006) 243-251
57. Schwarz A.J., Zocchi A., Reese T., Gozzi A., Garzotti M., Varnier G., Curcuruto O., Sartori I., Girlanda E., Biscaro B., Crestan V., Bertani S., Heidbreder C., and Bifone A. Concurrent pharmacological MRI and in situ microdialysis of cocaine reveal a complex relationship between the central hemodynamic response and local dopamine concentration. Neuroimage 23 (2004) 296-304
58. Slifstein M., Parsey R.V., and Laruelle M. Derivation of [(11)C]WAY-100635 binding parameters with reference tissue models: effect of violations of model assumptions. Nucl. Med. Biol. 27 (2000) 487-492
59. Spencer T.J., Biederman J., Ciccone P.E., Madras B.K., Dougherty D.D., Bonab A.A., Livni E., Parasrampuria D.A., and Fischman A.J. PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short- and long-acting oral methylphenidate. Am. J. Psychiatry 163 (2006) 387-395
60. Szabo Z., Owonikoko T., Peyrot M., Varga J., Mathews W.B., Ravert H.T., Dannals R.F., and Wand G. Positron emission tomography imaging of the serotonin transporter in subjects with a history of alcoholism. Biol. Psychiatry 55 (2004) 766-771
61. 11C]FLB 457. Int. J. Neuropsychopharmacol. 6 (2003) 361-370
62. Tang A., Bungay P.M., and Gonzales R.A. Characterization of probe and tissue factors that influence interpretation of quantitative microdialysis experiments for dopamine. J. Neurosci. Methods 126 (2003) 1-11
63. Volkow N.D., and Swanson J.M. Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. Am. J. Psychiatry 160 (2003) 1909-1918
64. Volkow N.D., Mullani N., Gould L., Adler S.S., Guynn R.W., Overall J.E., and Dewey S. Effects of acute alcohol intoxication on cerebral blood flow measured with PET. Psychiatry Res. 24 (1988) 201-209
65. 11C]raclopride in the human brain. Synapse 16 (1994) 255-262
66. Volkow N.D., Ding Y.S., Fowler J.S., Wang G.J., Logan J., Gatley J.S., Dewey S., Ashby C., Liebermann J., Hitzemann R., et al. Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. Arch. Gen. Psychiatry 52 (1995) 456-463
67. Volkow N.D., Fowler J.S., Gatley S.J., Dewey S.L., Wang G.J., Logan J., Ding Y.S., Franceschi D., Gifford A., Morgan A., Pappas N., and King P. Comparable changes in synaptic dopamine induced by methylphenidate and by cocaine in the baboon brain. Synapse 31 (1999) 59-66
68. Yoder K.K., Wang C., and Morris E.D. Change in binding potential as a quantitative index of neurotransmitter release is highly sensitive to relative timing and kinetics of the tracer and the endogenous ligand. J. Nucl. Med. 45 (2004) 903-911
69. Zald D.H., Boileau I., El-Dearedy W., Gunn R., McGlone F., Dichter G.S., and Dagher A. Dopamine transmission in the human striatum during monetary reward tasks. J. Neurosci. 24 (2004) 4105-4112
70. Zhou Y., Huang S.-C., and Bergsneider M. Linear ridge regression with spatial constraint for generation of parametric images in dynamic positron emission tomography studies. Nuclear Science, IEEE Transactions on 48 (2001) 125-130
71. Zhou Y., Huang S.C., Bergsneider M., and Wong D.F. Improved parametric image generation using spatial-temporal analysis of dynamic PET studies. NeuroImage 15 (2002) 697-707
72. Zhou Y., Chen M.K., Endres C.J., Ye W., Brasic J.R., Alexander M., Crabb A.H., Guilarte T.R., and Wong D.F. An extended simplified reference tissue model for the quantification of dynamic PET with amphetamine challenge. NeuroImage 33 (2006) 550-563